Bcl-xL activity influences outcome of the mitotic arrest
Microtubule-targeting (MT) drugs taxanes and vinca alkaloids are widely used as chemotherapeutic agents against different tumors for more than 30 years because of their ability to block mitotic progression by disrupting the mitotic spindle and activating the spindle assembly checkpoint (SAC) for a p...
Na minha lista:
Principais autores: | M. Suleimenov (Autor), S. Bekbayev (Autor), M. Ten (Autor), N. Suleimenova (Autor), M. Tlegenova (Autor), A. Nurmagambetova (Autor), S. Kauanova (Autor), I. Vorobjev (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Editorial: Cytoskeleton in the focus of anti-cancer therapy: In a search of novel biomarkers and combinatorial therapy approaches
por: I. Vorobjev, et al.
Publicado em: (2022) -
BCL-xL is correlated with disease severity in neonatal infants with early sepsis
por: Wu Wenshen, et al.
Publicado em: (2021) -
MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53
por: Mengyang Chang, et al.
Publicado em: (2022) -
Bcl-xL DNAzymes promote radiosensitivity and chemosensitivity in colorectal cancer cells via enhancing apoptosis
por: Zhen Yu, et al.
Publicado em: (2022) -
Doxorubicin Changes Bax /Bcl-xL Ratio, Caspase-8 and 9 in Breast Cancer Cells
por: Simin Sharifi, et al.
Publicado em: (2015)